Market Survey on Fibrinogen Concentrates

Healtcareresearch25 Nov, 2021Health

According to the report, the global fibrinogen concentrates market was valued over US$ 350 Mn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031. Fibrinogen concentrate is specified for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. Low levels of fibrinogen could lead to thrombosis, blood clot formation inside the blood vessel, interrupting the normal blood flow through the circulatory system. Fibrinogen is a glycoprotein in vertebrates used as a medicine for blood disease, which helps in the formation of blood clots. In severely bleeding patients, fibrinogen concentrate significantly improves whole blood clot firmness and reduces the postoperative transfusion requirements.